Atopic disease, rhinitis and conjunctivitis, and upper respiratory infections.
This review highlights recent information on the topics of atopic diseases and upper respiratory infections. Recent findings on the costs and therapies of atopic dermatitis are discussed. New insights into egg allergy, peanut allergy, food-induced exercise anaphylaxis, and the management of food allergy are presented. Topics highlighted in the section on asthma include airway remodeling and anti-inflammatory therapy, leukotriene synthesis inhibitors and receptor antagonists, steroid resistance and alternative therapy, and new delivery systems. Recent publications in the areas of allergic rhinoconjunctivitis and upper respiratory infections are also reviewed.
Schneider
L C
LC
Children's Hospital, Boston, MA 02115, USA.
Lester
M R
MR
D018927:Anti-Asthmatic Agents / Q000008:administration & dosage; D010367:Arachis / Q000009:adverse effects; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology; D002648:Child; D003233:Conjunctivitis, Allergic / Q000188:drug therapy; D003876:Dermatitis, Atopic / Q000276:immunology / Q000628:therapy; D016503:Drug Delivery Systems; D004531:Eggs / Q000009:adverse effects; D005512:Food Hypersensitivity / Q000276:immunology / Q000517:prevention & control; D006801:Humans; D015289:Leukotrienes / Q000627:therapeutic use; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy
D018927:Anti-Asthmatic Agents; D015289:Leukotrienes